MXPA03008587A - Metodo para producir una vacuna. - Google Patents
Metodo para producir una vacuna.Info
- Publication number
- MXPA03008587A MXPA03008587A MXPA03008587A MXPA03008587A MXPA03008587A MX PA03008587 A MXPA03008587 A MX PA03008587A MX PA03008587 A MXPA03008587 A MX PA03008587A MX PA03008587 A MXPA03008587 A MX PA03008587A MX PA03008587 A MXPA03008587 A MX PA03008587A
- Authority
- MX
- Mexico
- Prior art keywords
- antibodies
- autologous
- vaccine
- ligands
- bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Abstract
Se describe un metodo para producir una vacuna que contiene anticuerpos autologos, el metodo esta caracterizado por los siguientes pasos: - proporcionar un fluido que contenga anticuerpos de un fluido corporal que contiene anticuerpos autologos o de preparaciones de celulas o tejidos autologos, - tratar el fluido que contenga anticuerpos con un portador solido en el cual han sido inmovilizados los ligandos que se unen a un cierto grupo de anticuerpos, con la condicion de que, como los ligandos, no se utilicen anticuerpos o sus fragmentos con el mismo idiotipo, los cuales se dirigen contra los antigenos asociados con tumores, - recuperar los anticuerpos que se unen a los ligandos, y - preparar los anticuerpos recuperados en una vacuna autologa, la cual comprende una cantidad eficaz de algunos microgramos hasta un gramo de anticuerpos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0047001A AT410636B (de) | 2001-03-23 | 2001-03-23 | Verfahren zur herstellung eines impfstoffes |
| PCT/AT2002/000091 WO2002080966A2 (de) | 2001-03-23 | 2002-03-20 | Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03008587A true MXPA03008587A (es) | 2004-06-30 |
Family
ID=3674741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03008587A MXPA03008587A (es) | 2001-03-23 | 2002-03-20 | Metodo para producir una vacuna. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040191242A1 (es) |
| EP (1) | EP1370289A2 (es) |
| JP (1) | JP2004524369A (es) |
| CN (1) | CN1522155A (es) |
| AT (1) | AT410636B (es) |
| BR (1) | BR0208641A (es) |
| CA (1) | CA2441499A1 (es) |
| HU (1) | HUP0303638A3 (es) |
| MX (1) | MXPA03008587A (es) |
| NO (1) | NO20034145L (es) |
| PL (1) | PL363720A1 (es) |
| SK (1) | SK11732003A3 (es) |
| WO (1) | WO2002080966A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT410637B (de) * | 2001-06-01 | 2003-06-25 | Igeneon Krebs Immuntherapie | Verwendung von polyklonalen immunglobulinen |
| WO2005090403A2 (en) * | 2004-03-12 | 2005-09-29 | Biovest International, Inc. | Method and apparatus for antibody purification |
| CN101646783B (zh) * | 2007-02-21 | 2014-11-05 | 奥斯陆大学医院Hf | 新型癌症标记物 |
| EP2236520A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Stabilizing composition for immobilized biomolecules |
| WO2022103871A1 (en) * | 2020-11-10 | 2022-05-19 | Wyomingv Immune, Inc. | Therapeutic compositions for the treatment of covid-19 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4436558A1 (de) * | 1994-10-13 | 1996-04-18 | Vitorgan Arzneimittel Gmbh | Verfahren zur Herstellung von humanen Impfstoffen gegen allergieauslösende Substanzen |
| AU705010B2 (en) * | 1994-11-16 | 1999-05-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona, The | Human antibodies to t-cell receptor peptides and methods for their preparation |
| DE19538641C2 (de) * | 1995-10-05 | 2000-09-21 | Privates Inst Bioserv Gmbh | Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung |
| WO1998026086A1 (en) * | 1996-12-11 | 1998-06-18 | University Of Florida | Novel methods and compositions for treatment of autoimmune diseases |
| US7022036B2 (en) * | 2003-05-21 | 2006-04-04 | Prototoy Llc | Electronic throw-and-catch game |
-
2001
- 2001-03-23 AT AT0047001A patent/AT410636B/de not_active IP Right Cessation
-
2002
- 2002-03-20 PL PL02363720A patent/PL363720A1/xx not_active Application Discontinuation
- 2002-03-20 CA CA002441499A patent/CA2441499A1/en not_active Abandoned
- 2002-03-20 HU HU0303638A patent/HUP0303638A3/hu unknown
- 2002-03-20 WO PCT/AT2002/000091 patent/WO2002080966A2/de active Application Filing
- 2002-03-20 CN CNA028088387A patent/CN1522155A/zh active Pending
- 2002-03-20 MX MXPA03008587A patent/MXPA03008587A/es not_active Application Discontinuation
- 2002-03-20 BR BR0208641-7A patent/BR0208641A/pt not_active Application Discontinuation
- 2002-03-20 SK SK1173-2003A patent/SK11732003A3/sk not_active Application Discontinuation
- 2002-03-20 US US10/472,876 patent/US20040191242A1/en not_active Abandoned
- 2002-03-20 EP EP02706509A patent/EP1370289A2/de not_active Withdrawn
- 2002-03-20 JP JP2002579005A patent/JP2004524369A/ja active Pending
-
2003
- 2003-09-17 NO NO20034145A patent/NO20034145L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002080966A3 (de) | 2003-09-12 |
| CN1522155A (zh) | 2004-08-18 |
| WO2002080966A8 (de) | 2003-01-23 |
| HUP0303638A2 (hu) | 2004-01-28 |
| JP2004524369A (ja) | 2004-08-12 |
| PL363720A1 (en) | 2004-11-29 |
| BR0208641A (pt) | 2004-03-09 |
| CA2441499A1 (en) | 2002-10-17 |
| SK11732003A3 (sk) | 2004-03-02 |
| HUP0303638A3 (en) | 2004-10-28 |
| NO20034145L (no) | 2003-11-07 |
| EP1370289A2 (de) | 2003-12-17 |
| WO2002080966A2 (de) | 2002-10-17 |
| AT410636B (de) | 2003-06-25 |
| ATA4702001A (de) | 2002-11-15 |
| US20040191242A1 (en) | 2004-09-30 |
| NO20034145D0 (no) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3036229T3 (en) | Method for the production of antihuman antigen receptors and uses thereof | |
| AU2342897A (en) | Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications | |
| AU3889399A (en) | Vaccine delivery system | |
| MD1374G2 (ro) | Anticorpi monoclonali imunostimulatori, procedeu de obţinere a acestora, linii celulare, metodă de tratare a maladiilor şi compoziţie farmaceutică | |
| AU3117201A (en) | Methods and compositions for generating human monoclonal antibodies | |
| IL125590A (en) | Peptide immunogens, process for their preparation and use thereof as vaccines against allergies | |
| AU2003215188A1 (en) | Fusion proteins of humanized g250 specific antibodies and uses thereof | |
| WO2004005470A3 (en) | Antibodies to non-shed muc1 and muc16, and uses thereof | |
| WO2000056901A3 (en) | Linear and circular expression elements | |
| NZ514228A (en) | Method of Expressing Antigens on the Surface of Antigen Presenting Cells by Photochemical Internalisation | |
| ATE233102T1 (de) | Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten | |
| WO2002036790A3 (en) | Influenza virus vector for infection of dendritic cells | |
| AU2002354806A1 (en) | Parathyroid hormone antibodies and related methods | |
| CA2348026A1 (en) | Antibodies against semp1, methods for their production and uses thereof | |
| MXPA03008587A (es) | Metodo para producir una vacuna. | |
| DE69833455D1 (de) | Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs) | |
| EP1820514A3 (en) | Therapeutic compositions that produce an immune response by altering the antigen | |
| WO2002047613A3 (en) | Immunogenic cancer peptides and uses thereof | |
| PL339513A1 (en) | Vaccines against colonisation by campylobacter, antigenic campylobacter proteins and antibodies against campylobacter for said vaccines and method of obtaining the last mentioned ones | |
| AU2002326318A1 (en) | Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer | |
| ZA904457B (en) | Methods for enhancing the rate of modification of metastable bonds | |
| NZ320837A (en) | Peptides derived from tumor rejection antigen precursors and presented by hla-b44 useful in diagnostic and therapeutic methodologies | |
| ATE508771T1 (de) | Zytoprotektion durch phosphotyrosin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |